[Do oral antidiabetics play a part in the cardiovascular mortality of diabetics? Apropos of the University Group Diabetes Program report and the controversies it has raised].
D001786:Blood Glucose / Q000032:analysis; D002318:Cardiovascular Diseases / Q000209:etiology; D003920:Diabetes Mellitus / Q000188:drug therapy*; D003925:Diabetic Angiopathies / Q000209:etiology / Q000401:mortality*; D004035:Diet Therapy; D005951:Glucose Tolerance Test; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D007328:Insulin / Q000008:administration & dosage; D049528:Insulin, Long-Acting / Q000008:administration & dosage; D014044:Tolbutamide / Q000008:administration & dosage / Q000009:adverse effects
D001786:Blood Glucose; D007004:Hypoglycemic Agents; D007328:Insulin; D049528:Insulin, Long-Acting; D014044:Tolbutamide
Les antidiabétiques oraux jouent-ils un rôle dans la mortalité cardiovasculaire du diabète? A propos du rapport de l'U.G.D.P. et des controverses qu'il a suscitées.